Skip to content

Individualised Preoperative Optimisation of Glycaemic Control in Patients with Diabetes Mellitus

Individualised Preoperative Optimisation of Glycaemic Control in Patients with Diabetes Mellitus - The IPOD trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON48583
Enrollment
256
Registered
2019-10-09
Start date
2020-02-06
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes diabetes mellitus

Interventions

On the day of preoperative consultation, HbA1c will be measured. Patients with an HbA1c =53 mmol/mol and

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Diabetes mellitus type 2 (diagnosis at least 3 months prior to pre-operative screening) - Age 18 - 85 years - Elective non-cardiac surgery - Scheduled for surgery at least 7 days from date of screening - Informed consent

Exclusion criteria

Exclusion criteria: - Bariatric surgery - Palliative surgery - Outpatient or day case surgery - (Potentially) pregnant or breast-feeding - Unable to communicate in Dutch or English, psychiatric disorder, known therapy incompliance or deemed unfit by the researchers for another reason

Design outcomes

Primary

MeasureTime frame
The primary endpoint of the study will be the preoperative fasting glucose concentration.

Secondary

MeasureTime frame
Secondary outcomes are postoperative blood glucose concentrations, incidence of hyperglycaemia and hypoglycaemia (glucose >10 mmol l-1 or

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)